Between 1987 and 1999, 1118 radiological treatments (726 Declotting simple dilations, 135 dilations with stent placement, 257 declottings) were performed in 439 consecutive haemodialysis Thrombosed accesses were routinely declotted percutanaccesses of 364 patients in a single radiological centre. They eously from 1992. The initial technique [9] combined local comprised 209 forearm AVFs, 74 upper arm AVFs and 156 infusion of urokinase for 2 h and secondary manual aspiraprosthetic grafts (21 bovine carotid arteries, 135 PTFE ). tion of residual clots through 8F large lumen catheters Data were collected retrospectively before 1992 (63 cases) ('Brite-Tip', vertebral or multipurpose curve, Cordis, Miami, and prospectively thereafter (376 cases). The first radiological FL). The urokinase infusion stage was abandoned from 1994 procedure was in 155 cases a simple dilation versus 54 and since that time clots have been directly aspirated after declottings in forearm AVFS, 65 dilations versus nine declot-placement of two 7F or 8F introducer-sheaths in opposite directions to gain access to both the arterial inflow and the tings in upper arm AVFs and 98 dilations versus 58 declotvenous outflow [10] . An underlying stenosis was unmasked tings in grafts.
and dilated in all cases. Grafts were located in the forearm in 94 cases (63 loop, 31 straight), in the upper arm in 59 cases (all straight), and in the thigh in three cases (one loop, two straight). In the Evolution from 1987 to 1999 forearm fistula, upper arm fistula and prosthetic graft groups, the proportions of women were 37, 45 and 50% respectively: Balloon dilation was the only percutaneous method used in the difference is significant between the forearm AVF and 1987. The complications, including early recurring stenoses, the graft group (P<0.02). The proportions of diabetics were were treated surgically. From 1989, some selected cases were 15, 21 and 20% respectively (NS). The proportions of black treated by placement of a Wallstent that became routinely people were 0.5, 0 and 2% in the three groups respectively. available from 1991. Early recurring stenoses that were Mean patient age was 63 years in the forearm AVF group operated on before the availability of stents were treated by and 64 in both the upper arm AVF and graft groups. Patients stent placement from 1992 after multidisciplinary discussion. were referred from six different hemodialysis centres (only Covered stents became available from 1993. two in 1987, four additional centres from 1992), representing
After occasional successful attempts in 1991, systematic 18 different nephrologists. From 1992, the vast majority of radiological treatment of thrombosed AVFs and grafts was vascular access problems were, therefore, referred directly by initiated from 1992 and the surgical option was abandoned. the nephrologists to the radiology centre for diagnostic From 1994, manual catheter-directed thromboaspiration was angiography, and for concomitant treatment when possible. the single percutaneous technique used. Long stenoses and All radiological interventions were outpatient procedures, chronic occlusions were initially considered as contraindicaexcept when significant clinical complications occurred imme-tions for dilation, except for central veins. Improvement of diately or when the patients underwent their dialysis treat-catheters and guide wires from 1992 and the routine availabilment late in the evening after declotting.
ity of stents led to reconsideration of the radiological We now describe the details of the radiological approach approach. from 1987.
Immature native fistulas were initially considered to be contraindications to any interventional radiology procedure. Encouraging results obtained incidentally from 1994 led us to consider that non-anastomotic stenoses on the feeding Dilation artery or on the vein could be successfully treated by percutaneous means. Similarly, thrombosed immature The principles of the dilation technique were those described fistulas were declotted percutaneously from 1995 if it was in 1993 [2] . Dilation was performed after direct puncture of established that the fistula had been successfully used for the vascular access in the direction of but far enough from dialysis at least once. the stenosis to dilate and high pressure balloons that can be In 1999, the only absolute contraindications to percutaninflated to 25 atmospheres ('Blue-Max', Medi-Tech, Natick, eous treatment were local infection, never previously used Ma, or 'Centurion', Bard, Covington, GA, USA) were thrombosed immature fistulas and hand ischaemia with routinely used for a mean inflation time of 3 min. stenosis on the fistula itself.
Surveillance Stents
Surveillance and monitoring after interventional radiology treatments was the responsibility of the nephrologists who Only self-expandable stents were used: the Wallstent from initially referred the patients. The results are reported according to the Kaplan-Meier lifeIndications for stent placement comprised complications table method. Success was defined as a less than 30% residual and limitations of dilation: acute ruptures not controlled by stenosis and/or normalization of the clinical abnormalities prolonged balloon inflation, greater than 30% residual sten-after dilation and as the ability to perform at least one full osis despite no residual waisting on the balloon, and early dialysis treatment after declotting. Major complications were recurring restenosis (<6 months). Stents were also placed to defined as those with impairing clinical consequences and treat aneurysms. No anticoagulants or antiplatelet agents that necessitated an additional intervention or inpatient hospitalization. Primary patency was considered to begin on were given after either dilation or stent placement. the day of the first radiological procedure and to end on the failures. Primary patency rates at 1 year were 50±4% day of access failure or further reintervention (radiological for all (failing+thrombosed) forearm AVFs (n=64), or surgical ). Secondary patency included all further radiolo-34±8% for all upper arm AVFs (n=13) and 25±4% gical therapy (dilation, stent placement, declotting) but ended for all grafts (n=27). There was a significant difference with any surgical intervention. Death and renal transplanta-in primary patency rates between forearm AVFs and tion with a patent fistula were considered to be the end of grafts at 1 year (P<0.05).
follow-up.
Secondary patency rates at 1 year were 85±4% for
The interval between interventions was defined as the failing forearm AVFs (n=88), 80±8% for thrombosed duration of patency between two radiological interventions forearm AVFs (n=19), 82±6% for failing upper arm performed to maintain or to restore patency. Mean intervals between interventions were calculated as follows. The follow-AVFs (n=20), 65±27% for thrombosed upper arm up time after the first successful radiological procedure until AVFs (n=2), 92±3% for failing grafts (n=60) and the last reintervention was divided by the number of proced-75±8% for thrombosed grafts (n=24). At 4 years, ures performed. For patients with more than 6 months secondary patency rates were 77±8% for failing forefollow-up without reintervention, the current follow-up arm AVFs (n=20), 65±17% for thrombosed forearm period (at patient's death, renal transplantation or in AVFs (n=5), 51±15% for failing upper arm AVFs September 1999) was considered to be the (underestimated ) (n=6), 60±10% for failing grafts (n=15) and interval between interventions. The paired Student's t-test 24±15% for thrombosed grafts (n=2). Secondary was used for comparison of patency rates and intervals. A patency rates for all forearm fistulas, for all upper arm P value of 0.05 was used to determine statistical significance.
fistulas and for all grafts are presented in Tables 3  and 4 .
To achieve these secondary patency rates, a total of Results 311 simple dilations, 18 stent placements and 60 declottings were performed in the 209 forearm AVFs. In the Clinical abnormalities and location of stenoses 74 upper arm AVFs, they comprised 136 dilations, 37 Clinical abnormalities leading to first radiological pro-stent placements and 39 declottings. In the 156 grafts, cedures varied in frequency according to the type of they comprised 279 dilations, 80 stent placements and vascular access and they were of course influenced by 158 declottings. the location of stenoses ( Table and Fig . 1 ). For native forearm fistulas, stenoses predominated in the anastoComplications motic area, the majority leading to inflow problems. For upper arm fistulas and grafts, stenoses predomin-The mortality rate within 1 month was 2.1% in the ated in the venous outflow and increased venous forearm AVF, 1.9% in the upper arm AVF and 1.8% pressure was the most frequent clinical situation. in the graft groups of patients, respectively. However, Thrombosis resulting from delayed diagnosis of sten-no death was clearly imputable to the radiological osis was the first clinical event three times more often procedure. Significant complications occurred in 2.1% in grafts than in upper arm fistulas.
of forearm AVF, 1.9% of upper arm AVF and 2.1% The vast majority of stenoses (86%) were less than of graft cases, respectively. They included access loss 2 cm long. Only 2.3% of patients were referred first for because of uncontrolled rupture (two cases), acute a problem related to stenosis of a subclavian or brachi-pseudoaneurysms (on puncture site or on a dilated ocephalic vein and 6.1% of the patients were dilated area) requiring surgery within 1 week (five cases), local at least once on central veins during the entire follow-or general infection (five cases), haematoma requiring up period. surgery (two cases), pulmonary embolism (one case), pulmonary oedema by volume overload (one case), mesenteric infarction (one case), metabolic acidosis of Cumulative patency rates unknown origin (one case), need for blood transfusion Primary patency rates after inaugural dilation of failing (three cases) and iododermitis (two cases). Not all fistulas or grafts or declotting of failed fistulas and complications were imputable to the radiological prografts are detailed in Table 2 and they include initial cedures and complications such as access loss because of uncontrolled ruptures occurred early in our experience before stents were available. Minor complications arm AVFs (mainly in the final arch of the cephalic basilic fistulas), stents being necessary in 7/31 cases two stent migrations (one Wallstent and one Passager) with subsequent percutaneous retrieval of stents. (23%). In grafts, rupture occurred in 3.8% of cases, with resort to stents in 5/20 cases (25%). Stenoses Transient arterial embolisms during access declotting procedures were not counted as complications since all resistant to dilation occurred in 1.3% of forearm AVFs, 4.8% of upper arm AVFs (mainly in the final arch of of them were immediately successfully treated by thromboaspiration and were considered to be simple the cephalic vein) and 1.6% of grafts.
Specific complications of stent placement included technical difficulties. Statistically poorly significant figures, i.e. those resulting from fewer than 10 patients or with a greater than 10% standard error, are in parentheses. The mean interval between radiological procedures for grafts was 10.05 months when the graft was first In the radiological group the lower rates are those achieved in the treated for stenosis on a patent access, in contrast to upper arm and the higher rates those achieved in the forearm. In the surgical group, the extremes are those reported in the meta-only 6.39 months when it was initially declotted (P= analysis of Mehta. 0.028). Grafts initially referred for thrombosis were significantly more often recently created (8.52 months) forearm AVFs (18.8±4.5 months) and thrombosed placement comprised acute rupture (16/135=12%), grafts (6.3±0.9 months). Although raw data look soft stenosis recoil (33/135=24%), stenoses recurring better, the difference between upper arm fistulas and within 6 months (77/135=57%), restenoses within 1 grafts either after inaugural dilation (10.91 versus 10.0 year but over 6 months (8/135=6%), and treatment months) or inaugural declotting (8.6 versus 6.3 months) of pseudoaneurysms (1/135=1%). Only six of the did not reach significance. The mean interval between initial stent placements involved stenoses in subclavian maintenance reinterventions for all forearm AVFs was or brachiocephalic veins (one in the outflow of a 18.3±1.8 months, much better than for grafts forearm AVF, three in the outflow of an upper arm (8.7±0.8 months, P<0.001) and than for upper arm AVF and two of a graft). When a stent was placed for fistulas (10.6±1.8 months, P<0.01). However, the 1.9 early recurring stenosis (<6 months), the mean interval months difference between grafts and upper arm AVFs between reinterventions increased from 4.1±0.7 to 9.7±1.1 months in forearm AVFs (multiplied by 2.4, was not significant.
Influence of the age of the vascular access
much more rewarding, with higher secondary patency rates from the second year and many fewer maintenThe interval between reinterventions was significantly ance reinterventions overall. The ratio of reintervenshorter in forearm AVFs of less than 1 year (15.94 tions is 1 to 4 in favour of forearm AVFs after surgical months) when compared with those of more than 1 creation in the compilation of Mehta [14] and the ratio year (30.2 months) (P<0.04). This was also true for is 1 to 7 in Hodges's recent single centre study [15] . grafts (6.71 versus 12.84 months, P<0.001). The This ratio is lower but still very significant after radiolonumber of thrombosed AVFs was too small in the gical revision in our series (1 to 2 after dilation, 1 to upper arm group to allow similar comparison. The 3 after declotting). Both surgical and radiological data grafts with mean reintervention intervals of less than confirm that a forearm fistula is the access of choice 6 months were clearly more recently created (6.91 and is not created often enough in some countries and months) than those with intervals greater than 6 centres because, as emphasized by Hodges et al. 'objectmonths (17.84 months) (P=0.0001).
ive measures such as patency rate or adequacy of dialysis have less influence on the choice of access than physician preference and geographic bias'.
Discussion
There are relatively few surgical reports allowing more direct comparison with radiology in the treatment of stenosis and thrombosis in AVFs and grafts. In All the results reported in this article originate from a single radiological centre and, therefore, unintentional 1997, Gray summarized the data available in the literature [3], which included some short randomized selection bias is possible. Other teams using other techniques in different populations might have different trials, and he concluded that 'the available literature suggests that percutaneous treatments are at least as conclusions.
For example, no differences were found in this study effective as surgery when long-term patencies are evaluated'. between forearm and upper arm grafts, or between straight and loop grafts, which explains why we conMore recent surgical series did not provide arguments for a different conclusion. Hodges et al. reported structed a single graft group for statistical purposes. Similarly, no differences were found between radio-a 36% 1-year primary patency rate after surgical revision of failing grafts, similar to the 29% rate of our cephalic and radio-or ulnar-basilic fistulas, or between brachiocephalic and transposed brachiobasilic fistulas, series which is between the 10 to 40% radiological rates of the literature [3, 15] . leading to the creation of a single forearm fistula group and a single upper arm fistula group. More extensive Oakes reported a 57% 1-year primary patency rate after surgical treatment of both failing and thrombosed series might, however, reveal differences in the future. For example, Safa [13] reported differences in outcome forearm AVFs, in agreement with our 50% rate, but surgery often consisted of making a clearly more between straight and loop grafts after dilation in a smaller group of patients than ours, but with a majority proximal anastomosis that sacrificed long venous segments [16 ] . Hodges, Marston, and Dougherty of grafts placed in the forearm whereas the majority of our straight grafts were in the upper arm. [15, [17] [18] reported 1-year primary patency rates ranging from 23 to 26% for thrombosed grafts after The vast majority of surgical reports provide lifetable analyses starting from the creation of the AVF surgical revision, which were not clearly better than our 17% rate which is between the 8 to 26% rates in or graft, with little or partial information concerning revisions, whereas this study reports data starting from the radiological literature [3] .
As there are now sufficient findings to show that the 'radiological revision' of the failing and failed accesses. There are, however, several points common surgical and radiological approaches can lead to similar results, the time has probably come for an open to both approaches. For example, long-term secondary patency rates are identical after surgical creation and discussion about the best indications for both techniques according to the lesion and its location, the radiological revision if we compare our radiological results with the surgical data of the meta-analysis of type of access and the patient's history.
During the long follow-up period of this study we Mehta published in 1991 [14] , both for AVFs and grafts ( Tables 3 and 4) . This means that radiologically-have dilated or declotted grafts placed by a first surgeon in four patients who were referred months or revised accesses have the same life expectancy as newly created fistulas or grafts and, therefore, that revisions years later for treatment of a failing or failed forearm native fistula created by a more experienced and dedicare not only desirable but effective. Surgical rates from Mehta's meta-analysis are nevertheless overestimated ated surgeon, who had simply requested prior venous mapping using upper limb venography. It should be since they stopped in 1989. The haemodialysed population is nowadays older and more debilitated, with more emphasized that in two cases the surgeon created an ulnar-basilic fistula, an excellent native forearm fistula diabetics, and the recent surgical rates published by Hodges [15] are for example below the lowest rates of which is strangely mentioned nowhere in the American DOQI-guidelines. Preoperative venous mapping by Mehta's review of the literature.
Lower initial success rates indicate that forearm either venography or duplex ultrasound is also probably the reason why our success rate (98%) is so high AVFs are not only more difficult to create but also more difficult to revise than grafts, but the outcome is in the treatment of clotted grafts: the surgeons had the benefit of venous mapping most of the times they of stenoses is also confirmed in grafts. In view of the results achieved with the radiological approach in the placed a graft, thus helping them choose the best site for venous anastomosis, and we know that poor out-treatment of stenosis and thrombosis in all types of haemodialysis access, our opinion is that the percutanflow veins are the major cause of technical failure in radiological series. The extensive use of preoperative eous approach can be attempted as an alternative to conventional surgery in the majority of cases, as long venography probably also explains why the 6.1% of our patients treated for central vein lesions are, for as the local physicians performing the percutaneous techniques are trained and convinced. example, clearly less than the 17% of another recent European study [8] : when a subclavian or brachioce-
